Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Sources of youth access to JUUL vaping products in the United States.

McKeganey N, Russell C, Katsampouris E, Haseen F.

Addict Behav Rep. 2019 Nov 11;10:100232. doi: 10.1016/j.abrep.2019.100232. eCollection 2019 Dec.

2.

Factors associated with past 30-day abstinence from cigarette smoking in adult established smokers who used a JUUL vaporizer for 6 months.

Russell C, Haseen F, McKeganey N.

Harm Reduct J. 2019 Nov 7;16(1):59. doi: 10.1186/s12954-019-0331-5.

3.

Harm and addiction perceptions of the JUUL e-cigarette among adolescents.

Russell C, Katsampouris E, McKeganey N.

Nicotine Tob Res. 2019 Sep 26. pii: ntz183. doi: 10.1093/ntr/ntz183. [Epub ahead of print]

PMID:
31556452
4.

Capital depreciation: The lack of recovery capital and post-release support for prisoners leaving the Drug Recovery Wings in England and Wales.

Lloyd C, Page G, McKeganey N, Russell C.

Int J Drug Policy. 2019 Aug;70:107-116. doi: 10.1016/j.drugpo.2019.06.012. Epub 2019 Jun 22.

PMID:
31238269
5.

Prevalence of Awareness and Use of JUUL E-cigarettes in a National Probability Sample of Adolescents in the United States.

McKeganey N, Russell C.

Am J Health Behav. 2019 May 1;43(3):591-605. doi: 10.5993/AJHB.43.3.13.

PMID:
31046889
7.
8.

Changing patterns of first e-cigarette flavor used and current flavors used by 20,836 adult frequent e-cigarette users in the USA.

Russell C, McKeganey N, Dickson T, Nides M.

Harm Reduct J. 2018 Jun 28;15(1):33. doi: 10.1186/s12954-018-0238-6.

9.

Change and Continuity in Vaping and Smoking by Young People: A Qualitative Case Study of A Friendship Group.

McKeganey N, Barnard M.

Int J Environ Res Public Health. 2018 May 17;15(5). pii: E1008. doi: 10.3390/ijerph15051008.

10.

Advice From Former-Smoking E-Cigarette Users to Current Smokers on How to Use E-Cigarettes as Part of an Attempt to Quit Smoking.

Russell C, Dickson T, McKeganey N.

Nicotine Tob Res. 2018 Jul 9;20(8):977-984. doi: 10.1093/ntr/ntx176.

PMID:
29065208
11.

Why Don't More Smokers Switch to Using E-Cigarettes: The Views of Confirmed Smokers.

McKeganey N, Dickson T.

Int J Environ Res Public Health. 2017 Jun 16;14(6). pii: E647. doi: 10.3390/ijerph14060647.

12.

Conspicuous by their abstinence: The limited engagement of heroin users in English and Welsh Drug Recovery Wings.

Page G, Templeton L, Grace S, Roberts P, McKeganey N, Russell C, Liebling A, Kougiali Z, Lloyd C.

Int J Drug Policy. 2016 Mar;29:49-56. doi: 10.1016/j.drugpo.2015.12.006. Epub 2015 Dec 23.

PMID:
26809934
13.

Tobacco control research: a tale of two Delphi groups.

McKeganey N, Russell C.

Addiction. 2016 Apr;111(4):747-8. doi: 10.1111/add.13251. Epub 2016 Jan 11. No abstract available.

PMID:
26754452
14.

The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus.

Reimer J, Wright N, Somaini L, Roncero C, Maremmani I, McKeganey N, Littlewood R, Krajci P, Alho H, D'Agnone O.

Eur Addict Res. 2016;22(2):99-106. doi: 10.1159/000438988. Epub 2015 Oct 2. Review.

15.

Tobacco plain packaging: Evidence based policy or public health advocacy?

McKeganey N, Russell C.

Int J Drug Policy. 2015 Jun;26(6):560-8. doi: 10.1016/j.drugpo.2015.03.004. Epub 2015 Mar 24. Erratum in: Int J Drug Policy. 2016 Jan;27:186.

PMID:
26041731
16.

Clear rhetoric and blurred reality: the development of a recovery focus in UK drug treatment policy and practice.

McKeganey N.

Int J Drug Policy. 2014 Sep;25(5):957-63. doi: 10.1016/j.drugpo.2014.01.014. Epub 2014 Jan 31.

PMID:
24582380
17.

Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.

McKeganey N, Russell C, Cockayne L.

J Subst Abuse Treat. 2013 Jan;44(1):97-102. doi: 10.1016/j.jsat.2012.04.003. Epub 2012 Jun 15.

PMID:
22703715
18.

Abstinence and harm reduction: can they work together?

McKeganey N.

Int J Drug Policy. 2011 May;22(3):194-5. doi: 10.1016/j.drugpo.2011.04.001. Epub 2011 May 7. No abstract available.

PMID:
21550791
19.

Community treatments for heroin and crack cocaine addiction.

McKeganey N.

Lancet. 2010 Jan 23;375(9711):278; author reply 278-9. doi: 10.1016/S0140-6736(10)60124-9. No abstract available.

PMID:
20109947
20.

Challenges of reliability and validity in the identification and monitoring of emerging drug trends.

Mounteney J, Fry C, McKeganey N, Haugland S.

Subst Use Misuse. 2010;45(1-2):266-87. doi: 10.3109/10826080903368598.

PMID:
20025453

Supplemental Content

Loading ...
Support Center